Skip to content

To assess the efficacy of Kalari Marma Chikitsa (an Ayurvedic procedure) for pain reduction in Sciatica cases

Neurobiological and biochemical assessment of pain perception after Kalari Marma Chikitsa in Sciatica - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090658
Enrollment
30
Registered
2025-07-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G55- Nerve root and plexus compressionsin diseases classified elsewhere

Interventions

None listed

Sponsors

ITRA, Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from sign and symptoms of sciatica for more than 1month. Patients within the age group 30-65 years, irrespective of gender, religion, occupation, and socioeconomic status will be included in the study. Patients willing to undergo trial. Patients with mild and moderate pain (upto grade 3) on a visual analogue scale. Patients coming under the minimal and moderate disability gradation of Oswestry Low Back Pain Disability Questionnaire.

Exclusion criteria

Exclusion criteria: Patients with red flag conditions in sciatica (muscle wasting of one or both leg, bowel or bladder dysfunction, progressive neurological deficits, saddle anesthesia, sudden onset bilateral radiculopathy, incapacitating pain and unrelenting night pain). Cauda equina syndrome. Fractures related to spine and hip joint. Tuberculosis, other infectious disease and malignancy of lumbosacral spine. Sciatica patients with associated symptoms like fever, nausea, unexplained weight loss and considerable loss of appetite will be excluded. Patients of controlled diabetes mellitus. Patients of controlled hypertension. Other diseases like cardiac diseases, renal diseases, endocrine disorders, severe anemia and malignancy. Pregnant or lactating female.

Design outcomes

Primary

MeasureTime frame
The primary outcome is to evaluate the change of leg pain intensity on the basis of VAS from baseline to week 2. To assess the change in pain perception by evaluating the changes in neurotransmitter levels before and after the treatment. Timepoint: 0 day and 14 day

Secondary

MeasureTime frame
Changes in paresthesia, stiffness and muscle power grading of muscles of affected lower limb. Changes in ROM. Changes in straight leg raise test. Changes in Sciatica Frequency and Bothersomeness Index (SFBI), it measures the frequency and symptom severity of sciatica with scores ranging from 0 to 24 respectively. Changes in Oswestry Low Back Pain Disability Questionnaire to assess the relief in sciatica grades. Timepoint: 0 day and 14 day.

Countries

India

Contacts

Public ContactIpsita Panda

Institute of teaching and research in Ayurveda

drtsdudhamal@gmail.com8849298620

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026